These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17916343)

  • 1. Characterization of circulating DNA in healthy human plasma.
    Suzuki N; Kamataki A; Yamaki J; Homma Y
    Clin Chim Acta; 2008 Jan; 387(1-2):55-8. PubMed ID: 17916343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for characterization of total circulating DNA.
    van der Vaart M; Pretorius PJ
    Ann N Y Acad Sci; 2008 Aug; 1137():92-7. PubMed ID: 18837930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of circulating DNA by parallel tagged sequencing on the 454 platform.
    van der Vaart M; Semenov DV; Kuligina EV; Richter VA; Pretorius PJ
    Clin Chim Acta; 2009 Nov; 409(1-2):21-7. PubMed ID: 19699193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
    Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
    Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors.
    Cherepanova AV; Tamkovich SN; Bryzgunova OE; Vlassov VV; Laktionov PP
    Ann N Y Acad Sci; 2008 Aug; 1137():218-21. PubMed ID: 18837950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haemodynamic role of blood-plasma circulating cell-free DNA and contained therein high-molecular-weight CpG-rich fraction in pathogenesis of arterial hypertension and atherosclerosis obliterans of carotid arteries].
    Konorova IL; Veĭko NN; Ershova ES; Antelava AL; Chechetkin AO
    Angiol Sosud Khir; 2009; 15(2):19-28. PubMed ID: 19806935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
    Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
    Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of circulating DNA in healthy human plasma.
    van der Vaart M; Pretorius PJ
    Clin Chim Acta; 2008 Sep; 395(1-2):186. PubMed ID: 18519034
    [No Abstract]   [Full Text] [Related]  

  • 10. Free DNA in serum and plasma from normal adults.
    Steinman CR
    J Clin Invest; 1975 Aug; 56(2):512-5. PubMed ID: 1150882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA integrity in plasma and serum of patients with malignant and benign diseases.
    Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free circulating DNA as possible tumour marker in colorectal cancer.
    Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of DNA level in human plasma].
    Fedorov NA; Ianeva IS; Skotnikova OI; Pan'kov VN
    Biull Eksp Biol Med; 1986 Sep; 102(9):281-3. PubMed ID: 3756326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
    Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
    Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction and characterization of circulating plasma DNA from patients with pulmonary embolism.
    Riboldi P; Asero R; Bregni M; Pettenati C; Zanussi C
    Boll Ist Sieroter Milan; 1985; 64(6):468-70. PubMed ID: 4096840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of porcine factor VII, X and comparison with human factor VII, X.
    Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J
    Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer.
    Ellinger J; Wittkamp V; Albers P; Perabo FG; Mueller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jan; 181(1):363-71. PubMed ID: 19010497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating hTERT DNA in early breast cancer.
    Divella R; Tommasi S; Lacalamita R; Daniele A; Abbate I; Garrisi VM; Savino E; Coviello M; Rubini V; Simone G; Paradiso A; Quaranta M
    Anticancer Res; 2009 Jul; 29(7):2845-9. PubMed ID: 19596972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.